Scholarlink

Purpose <p>Conflicting results have been reported on dietary factors in inflammatory bowel diseases (IBDs). Here, we compared the dietary intakes of IBD patients with those of paired healthy relatives (HRs), aiming to minimize the impact of genetic and environmental confounders.</p> Methods <p>Patients with Crohn’s disease (CD, <i>N</i> = 45) and ulcerative colitis (UC, <i>N</i> = 20), their paired HRs (N<sub>CD−HR</sub> = 45, N<sub>UC−HR</sub> = 20) and healthy non-relative (HNR, N<sub>CD−HNR</sub> = 25, N<sub>UC−HNR</sub> = 55) controls were recruited. Participants have kept dietary habits since the onset of IBDs and report no other recent digestive diseases or surgeries. Pre-illness dietary factors were assessed through 24-hour recall interviews. Statistical analyses included Analysis of Variance, Fisher’s exact tests, Wilcoxon rank sum tests, logistic regressions, Area Under the Receiver-Operator Curve (AUROC) analysis, and Least Absolute Shrinkage and Selection Operator (LASSO) regression.</p> Results <p>Dietary features identified in IBD patients using the HR controls differed from those identified using the HNR controls. For CD, lower intakes of vitamin C, dietary fiber, calcium, vegetables, decanoic acid (10:0), milk, dairy foods, and β-carotene were identified as risk factors when compared to HRs. LASSO regression highlighted milk, vegetables, and vitamin C as the most significant risk factors for CD. In UC patients, lower intakes of phosphorus, docosapentaenoic acid (DPA, 22:5, n-3), vitamins B-2 and B-12, and choline, along with a higher intake of α-carotene, were identified as risk factors compared to HRs. LASSO regression emphasized DPA, vitamins B-2 and B-12, and α-carotene as the most significant risk factors for UC.</p> Conclusion <p>Monitoring dietary intake patterns is crucial for the prevention and personalized treatment of CD and UC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dietary risk factors in Crohn’s disease and ulcerative colitis: a cohort study with paired healthy relatives as controls

  • 期刊论文

  • 发表日期：

    2025年3月12日

查看全文
  • Jun Hu,
  • Wanning Chen,
  • Ruixin Zhu,
  • Fang Yang,
  • Jinhong Xu,
  • Bingjie Xiang,
  • Yichen Li,
  • Wenxia Wang,
  • Lixin Zhu,
  • Guoxun Chen,
  • Min Zhi

摘要

Purpose

Conflicting results have been reported on dietary factors in inflammatory bowel diseases (IBDs). Here, we compared the dietary intakes of IBD patients with those of paired healthy relatives (HRs), aiming to minimize the impact of genetic and environmental confounders.

Methods

Patients with Crohn’s disease (CD, N = 45) and ulcerative colitis (UC, N = 20), their paired HRs (NCD−HR = 45, NUC−HR = 20) and healthy non-relative (HNR, NCD−HNR = 25, NUC−HNR = 55) controls were recruited. Participants have kept dietary habits since the onset of IBDs and report no other recent digestive diseases or surgeries. Pre-illness dietary factors were assessed through 24-hour recall interviews. Statistical analyses included Analysis of Variance, Fisher’s exact tests, Wilcoxon rank sum tests, logistic regressions, Area Under the Receiver-Operator Curve (AUROC) analysis, and Least Absolute Shrinkage and Selection Operator (LASSO) regression.

Results

Dietary features identified in IBD patients using the HR controls differed from those identified using the HNR controls. For CD, lower intakes of vitamin C, dietary fiber, calcium, vegetables, decanoic acid (10:0), milk, dairy foods, and β-carotene were identified as risk factors when compared to HRs. LASSO regression highlighted milk, vegetables, and vitamin C as the most significant risk factors for CD. In UC patients, lower intakes of phosphorus, docosapentaenoic acid (DPA, 22:5, n-3), vitamins B-2 and B-12, and choline, along with a higher intake of α-carotene, were identified as risk factors compared to HRs. LASSO regression emphasized DPA, vitamins B-2 and B-12, and α-carotene as the most significant risk factors for UC.

Conclusion

Monitoring dietary intake patterns is crucial for the prevention and personalized treatment of CD and UC.